Search results
Results from the WOW.Com Content Network
HIV-1 infection causes chronic inflammation and production of reactive oxygen species. [85] Thus, the HIV genome may be vulnerable to oxidative damage, including breaks in the single-stranded RNA. For HIV, as well as for viruses in general, successful infection depends on overcoming host defense strategies that often include production of ...
Acquired immunodeficiency syndrome (AIDS) is defined as an HIV infection with either a CD4 + T cell count below 200 cells per μL or the occurrence of specific diseases associated with HIV infection. [32] In the absence of specific treatment, around half of people infected with HIV develop AIDS within ten years. [32]
HIV seeks out and destroys CCR5 expressing CD4 + cells during acute infection. A vigorous immune response eventually controls the infection and initiates the clinically latent phase. However, CD4 + T cells in mucosal tissues remain depleted throughout the infection, although enough remain to initially ward off life-threatening infections.
HIV-associated nephropathy (HIVAN) refers to kidney disease developing in association with infection by human immunodeficiency virus, the virus that causes AIDS. The most common, or "classical", type of HIV-associated nephropathy is a collapsing focal segmental glomerulosclerosis (FSGS), though other forms of kidney disease may also occur. [ 1 ]
The Human Immunodeficiency Virus is a virus that causes Acquired Immunodeficiency Syndrome . HIV/AIDS can be transmitted sexually, via contaminated needles or blood transfusions, and from mother to child during pregnancy, birth or breast-feeding.
WHO Disease Staging System for HIV Infection and Disease was first produced in 1990 by the World Health Organization [1] and updated in 2007. [2] It is an approach for use in resource limited settings and is widely used in Africa and Asia and has been a useful research tool in studies of progression to symptomatic HIV disease .
HIV infection is becoming endemic in sub-Saharan Africa, which is home to just over 12% of the world's population but two-thirds of all people infected with HIV. [38] As of 2022, it is estimated that the adult HIV prevalence rate is 6.2%, a 1.2% increase from data reported in the 2011 UNAIDS World Aids Day Report.
In immunocompromised patients, such as those with HIV, the infection becomes much more deadly, as without a consistent or strong enough immune response following bradyzoite formation, tachyzoites can escape from the cysts, facilitating further systemic infection and inflammation. [8]